Intuitive Surgical, Inc. Overview
Pro stress-test →Intuitive Surgical is the global pioneer and market leader in robotic-assisted, minimally invasive surgery, best known for its da Vinci Surgical System. The company develops, manufactures, and markets surgical robotic systems and related instruments that enable physicians to perform complex procedures with superior visualization, precision, and ergonomic comfort, touching over 20 million patients globally.
Strategic Profile
Pro stress-test →Intuitive maintains formidable competitive moats through its installed base of da Vinci systems, recurring instrument revenue, and expanding digital/AI capabilities. The company is strategically investing 11-15% more in operating expenses for 2026 to accelerate da Vinci 5 adoption, expand into adjacent specialties, and scale international operations, positioning itself to sustain double-digit procedure growth and margin expansion despite near-term cost pressures.
Competitive Landscape
Pro stress-test →Intuitive Surgical maintains commanding market share in robotic-assisted surgery, though faces emerging competition from Medtronic's Hugo system and Johnson & Johnson's Ottava platform. Competitors are targeting both multi-port and single-port robotic procedures, but Intuitive's large installed base, deep surgeon familiarity, robust instrument ecosystem, and advancing digital/AI capabilities provide durable defensibility. The market is expanding rather than zero-sum, with growing global adoption of minimally invasive surgical techniques benefiting the category.
Industry Context
Intuitive Surgical, Inc. operates in Medical Device Manufacturing - Robotic-Assisted Surgery.
Key facts
Founded: 1995 · Headquarters: Sunnyvale, US · Revenue: $2.87B · Market cap: $173.4B